Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Change in Inventory (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Change in Inventory for 11 consecutive years, with $23540.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Inventory rose 110.7% to $23540.0 in Q4 2025 year-over-year; TTM through Nov 2025 was -$56190.0, a 86.91% increase, with the full-year FY2025 number at -$56190.0, up 86.91% from a year prior.
  • Change in Inventory was $23540.0 for Q4 2025 at Cryo Cell International, up from -$21511.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $183565.0 in Q3 2023 to a low of -$230459.0 in Q1 2023.
  • A 5-year average of -$77304.6 and a median of -$89638.5 in 2024 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: plummeted 10480.91% in 2022, then skyrocketed 263.37% in 2023.
  • Cryo Cell International's Change in Inventory stood at $91212.0 in 2021, then tumbled by 304.84% to -$186840.0 in 2022, then rose by 28.81% to -$133017.0 in 2023, then crashed by 65.37% to -$219969.0 in 2024, then soared by 110.7% to $23540.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Change in Inventory are $23540.0 (Q4 2025), -$21511.0 (Q3 2025), and -$92796.0 (Q2 2025).